Prof. Dr. Naim ATA

1. Clinical features of osteoporosis in patients with type 1 and type 2 diabetes in Türkiye: A nationwide study

YAVUZ D., HAYMANA C., AKKAN T., YALÇIN M. R., HEKİMSOY Z., Tasci I., et al.

Archives of Osteoporosis , cilt.21, sa.1, 2026 (SCI-Expanded, Scopus)

2. Comorbidity Burden in Lung Cancer and Malignant Pleural Mesothelioma: Nationwide Database Results of Turkey

Özdilekcan Ç., Özdemir T., Türkkanı M. H., ATA N., AKYOL M., KARATAŞ M., et al.

Medicina (Lithuania) , cilt.62, sa.5, 2026 (SCI-Expanded, Scopus)

3. Challenging The Diagnosis of Multiple Sclerosis: Histopathological Insights Gained Through Brain Biopsies Multipl Skleroz Tanısında Zorluk: Beyin Biyopsileriyle Elde Edilen Histopatolojik Bulgular

Taşkıran E., ÖZTÜRK B., ATA N., Birinci Ş., Emekli A. S., KÜRTÜNCÜ M.

Noropsikiyatri Arsivi , cilt.63, ss.277-281, 2026 (SCI-Expanded, Scopus, TRDizin)

4. Postoperative gabapentinoid use is associated with improved survival in glioblastoma: A nationwide population-based study

HANALİOĞLU Ş., ÇEKİÇ E., Gok E., Turken B., Sahin A., Bayram S., et al.

Neuro-Oncology Advances , cilt.8, sa.1, 2026 (ESCI, Scopus)

5. Central precocious puberty in Türkiye, 2018–2024: national incidence, prevalence, and changes across the COVID-19 period

Özer E., Çakır Gündoğan S., Bitkay A., Öztürk N., ATA N., Birinci Ş., et al.

Frontiers in Endocrinology , cilt.17, 2026 (SCI-Expanded, Scopus)

6. Perioperative risk factor analysis for mortality in patients undergoing total hip arthroplasty: A national database study from Türkiye

Artuç M., Birinci M., Hakyemez Ö. S., Bingöl İ., ATA N., Ülgü M. M., et al.

Acta Orthopaedica et Traumatologica Turcica , cilt.60, sa.2, 2026 (SCI-Expanded, Scopus)

7. Asthma data in Türkiye between 2016 and 2022: a nationwide descriptive and observational study covering the entire adult population

AKSU K., Solak G. T. V., ATA N., Türkkani M. H., Ülgü M. M., Birinci Ş., et al.

Turkish Journal of Medical Sciences , cilt.56, sa.2, ss.509-517, 2026 (SCI-Expanded, Scopus, TRDizin)

8. Revision arthrodesis after first metatarsophalangeal joint arthroplasty: A nationwide analysis of implant type and revision-related factors

ARSLAN A. K., Ülgen N. K., Yiğit N., BİNGÖL İ., ATA N., Birinci Ş., et al.

Foot and Ankle Surgery , 2026 (SCI-Expanded, Scopus)

9. Comparison of Mortality and Complications After Total Hip Arthroplasty in Patients with Sickle Cell Disease: A Retrospective Match-Controlled Study from Türkiye Orak Hücre Hastalığı Olan Hastalarda Total Kalça Artroplastisi Sonrası Mortalite ve Komplikasyonların Karşılaştırılması: Türkiye’den Retrospektif Eşleştirme Kontrollü Bir Çalışma

ÇAÇAN M. A., Birinci M., Hakyemez Ö. S., BİNGÖL İ., Öktem U., ATA N., et al.

Turkish Journal of Hematology , cilt.43, sa.2, ss.108-115, 2026 (SCI-Expanded, Scopus, TRDizin)

10. “Diagnostic pathways in femoroacetabular impingement, patterns of clinical visits, and MRI utilization before hip arthroscopy in Türkiye”

Kamaci S., Goker B., BİNGÖL İ., KOLAÇ U. C., YAŞAR N. E., Fidanci A. A., et al.

Scientific Reports , cilt.15, sa.1, 2025 (SCI-Expanded, Scopus)

11. Fracture analysis of working-age adults in Turkey: a 7-year national registry study

Yilmaz E. T., Kamaci S., BİNGÖL İ., Oral M., KOLAÇ U. C., YAŞAR N. E., et al.

BMC Musculoskeletal Disorders , cilt.26, sa.1, 2025 (SCI-Expanded, Scopus)

12. Real-world evidence from Türkiye on cancer risk and treatment exposure in multiple sclerosis: A histopathology-verified, registry-based study

ÖZTÜRK B., Taşkıran E., DEMİR S., Arat M. M., Siva A., ATA N., et al.

Multiple Sclerosis and Related Disorders , cilt.100, 2025 (SCI-Expanded, Scopus)

13. Prevalence and incidence of neuromyelitis optica spectrum disorder in Türkiye: A nationwide epidemiologic study

Taşkıran E., ÖZTÜRK B., DEMİR S., ATA N., Ülgü M. M., Birinci Ş., et al.

Multiple Sclerosis and Related Disorders , cilt.97, 2025 (SCI-Expanded, Scopus)

14. Prevalence, number of fractures, and hospital characteristics among the pediatric population with osteogenesis imperfecta: results from the nationwide registry of Türkiye

Görgün B., YAŞAR N. E., Bingöl İ., Dumlupinar E., ATA N., Ülgü M. M., et al.

Journal of Pediatric Orthopaedics Part B , cilt.34, sa.3, ss.249-256, 2025 (SCI-Expanded, Scopus)

15. Epidemiology of Pediatric Fractures and Effect of Socioeconomic Status on Fracture Incidence in Türkiye: A Nationwide Analysis of 2 Million Fractures

Kamaci S., YILMAZ T., Goker B., Dumlupinar E., ATA N., Ulgu M. M., et al.

Journal of Pediatric Orthopaedics , cilt.45, sa.4, 2025 (SCI-Expanded, Scopus)

16. Exploring the impact of developmental dysplasia of the hip on refugees with temporary protected status in Türkiye

Bingöl I., Taşcı M., YAŞAR N. E., ATA N., Ülgü M. M., Birinci Ş., et al.

Journal of Children's Orthopaedics , cilt.19, sa.1, ss.99-105, 2025 (SCI-Expanded, Scopus)

17. Epidemiological study of congenital myasthenic syndromes based on national electronic health database of Turkiye

İNAN B., ÖZTÜRK B., ATA N., Taskiran E., Birinci S., SONKAYA R., et al.

Northern Clinics of Istanbul , cilt.12, sa.4, ss.468-474, 2025 (ESCI, Scopus, TRDizin)

18. Prevalence, incidence and geographic distribution of familial Mediterranean fever in Turkey: a national cohort study

Satiş H., Gül A., Ayan G., Babaoğlu H., Armağan B., ERDEN A., et al.

Clinical and Experimental Rheumatology , cilt.43, sa.10, ss.1709-1714, 2025 (SCI-Expanded, Scopus)

19. A nationwide epidemiological study of myasthenia gravis in Turkey

İNAN B., ÖZTÜRK B., ATA N., Ulgu M. M., Birinci S., SONKAYA R., et al.

Journal of Neurology , cilt.272, sa.1, 2025 (SCI-Expanded, Scopus)

20. Epidemiological analysis of Lambert-Eaton myasthenic syndrome in Türkiye: insights from a nationwide electronic health database

İNAN B., ÖZTÜRK B., ATA N., Birinci S., EROĞLU E., KARADAŞ Ö., et al.

Frontiers in Neurology , cilt.16, 2025 (SCI-Expanded, Scopus)

21. Hip and knee arthroplasty in solid organ transplant patients: Results from a Turkish government-based health registry

Yılmaz M. K., Hakyemez Ö. S., Birinci M., Bingöl İ., ATA N., Ülgü M. M., et al.

Acta Orthopaedica et Traumatologica Turcica , cilt.59, sa.6, ss.452-457, 2025 (SCI-Expanded, Scopus, TRDizin)

22. From Conventional to Advanced Therapies: A National Health Registry Report (2016-2022) on DMARDs in Rheumatoid Arthritis Treatment in Turkey

ATA N., Satış H., KÜÇÜKŞAHİN O., KARABULUT E., Ayan G., ERDEN A., et al.

Biologics: Targets and Therapy , cilt.19, ss.331-339, 2025 (ESCI, Scopus)

23. Identifying Hip Arthroscopy Trends in Turkey

CIRDI Y. U., Bingol I., Kamacı S., Bayram S., ATA N., Ulgu M. M., et al.

Orthopaedic Journal of Sports Medicine , cilt.12, sa.12, 2024 (SCI-Expanded, Scopus)

24. Epidemiology and demographics of pediatric proximal femur fractures in Türkiye: Results from a government-based health registry

Söylemez M. S., Bingöl İ., YAŞAR N. E., Dumlupinar E., Ayvali M. O., ATA N., et al.

Journal of Pediatric Orthopaedics Part B , cilt.33, sa.5, ss.443-451, 2024 (SCI-Expanded, Scopus)

25. Shedding light on slipped capital femoral epiphysis: A nationwide study on Turkish population

Taşci M., Turhan Y., YAŞAR N. E., Bozkurt İ., Dumlupinar E., ATA N., et al.

Journal of Pediatric Orthopaedics Part B , cilt.33, sa.5, ss.426-431, 2024 (SCI-Expanded, Scopus)

26. Unseen Threefold Mortality After the First Ten Days in Hemodialysis Patients Following Joint Arthroplasty: A Nationwide Retrospective Cohort Study of 1,287 Arthroplasty Patients on Hemodialysis

Birinci M., Hakyemez Ö. S., Korkmaz O., Bingöl İ., ATA N., Ülgü M. M., et al.

Journal of Arthroplasty , cilt.39, sa.9, ss.2205-2212, 2024 (SCI-Expanded, Scopus)

27. Cemented Versus Uncemented Reverse Shoulder Arthroplasty Treatment of Proximal Humerus Fractures: National Shoulder Arthroplasty Data from Türkiye

Orhan Ö., Kaya İ., Bingöl İ., SARIKAYA B., Ayvali M. O., ATA N., et al.

CiOS Clinics in Orthopedic Surgery , cilt.16, sa.4, ss.602-609, 2024 (SCI-Expanded, Scopus)

28. Nusinersen therapy changed the natural course of spinal muscular atrophy type 1: What about spine and hip?

YAŞAR N. E., Ozdemir G., Uzun Ata E., Ayvali M. O., ATA N., Ulgu M., et al.

Journal of Children's Orthopaedics , cilt.18, sa.3, ss.322-330, 2024 (SCI-Expanded, Scopus)

29. Prevalence and incidence of multiple sclerosis in Turkey: A nationwide epidemiologic study

ÖZTÜRK B., Taşkıran E., DEMİR S., TUNCER M. A., KÜRTÜNCÜ M., Karabudak R., et al.

Multiple Sclerosis Journal , cilt.30, sa.7, ss.790-799, 2024 (SCI-Expanded, Scopus)

30. Association between hyponatremia, inflammation, and mortality in patients undergoing peritoneal dialysis: A nationwide observations

Erdogan B., ATA N., Caglayan M., GÖZÜKARA M. G., GEMCİOĞLU E., Sokmen F. C., et al.

Therapeutic Apheresis and Dialysis , cilt.28, sa.2, ss.265-271, 2024 (SCI-Expanded, Scopus)

31. The burden of scoliosis: a nationwide database study on demographics, incidence, and surgical rates

SAĞLAM Y., Bingöl I., YAŞAR N. E., Dumlupınar E., ATA N., Ülgü M. M., et al.

European Spine Journal , cilt.33, sa.2, ss.655-662, 2024 (SCI-Expanded, Scopus)

32. Diagnostic approach to heart failure in Türkiye

Ural D., Asarcikli L. D., ÇÖLLÜOĞLU İ. T., ŞAHİN A., ÇAVUŞOĞLU Y., YILMAZ M. B., et al.

Turkish Journal of Medical Sciences , cilt.54, sa.7, ss.1461-1469, 2024 (SCI-Expanded, Scopus, TRDizin)

33. Gastrointestinal bleeding among oral anticoagulant users: a comprehensive 7-year retrospective review using Türkiye’s national health data system

YILMAZ ÇAKMAK N., ATA N., Güven S. C., GEMCİOĞLU E., Çağlayan M., Ülgü M., et al.

Turkish Journal of Medical Sciences , cilt.54, sa.5, ss.1005-1012, 2024 (SCI-Expanded, Scopus, TRDizin)

34. Impact of celiac disease in Behçet’s syndrome patients: a study based on the database of Türkiye

YILMAZ ÇAKMAK N., ATA N., Güven S. C., GEMCİOĞLU E., Ülgü M. M., Birinci Ş.

Turkish Journal of Medical Sciences , cilt.54, sa.3, ss.493-501, 2024 (SCI-Expanded, Scopus, TRDizin)

35. Fracture Patterns and Mortality in Osteopetrosis: A 7-year Retrospective Analysis from Türkiye’s National Registry

BİNGÖL O., YAŞAR N. E., Özdemir G., Bekmez Ş., Söylemez M. S., Dumlupinar E., et al.

Journal of Pediatric Orthopaedics , cilt.44, sa.1, 2024 (SCI-Expanded, Scopus)

36. Nationwide study on the prevalence of rheumatoid factor and anticitrullinated peptide positivity and their contribution to rheumatoid arthritis diagnosis

Satiş H., ERDEN A., BİLGİN E., Ayan G., Armağan B., TECER D., et al.

Turkish Journal of Medical Sciences , cilt.54, sa.5, ss.949-955, 2024 (SCI-Expanded, Scopus, TRDizin)

37. Epidemiology of heart failure in Türkiye

ATA N., ÇÖLLÜOĞLU İ. T., ŞAHİN A., YILMAZ M. B., Nalbantgil S., Birinci Ş., et al.

Turkish Journal of Medical Sciences , cilt.54, sa.7, ss.1447-1454, 2024 (SCI-Expanded, Scopus, TRDizin)

38. Outcomes of patients with heart failure in Türkiye

ŞAHİN A., YILMAZ M. B., Çelik A., ÇÖLLÜOĞLU İ. T., Ural D., Asarcikli L. D., et al.

Turkish Journal of Medical Sciences , cilt.54, sa.7, ss.1488-1496, 2024 (SCI-Expanded, Scopus, TRDizin)

39. Medical and advanced heart failure therapies in Türkiye

Nalbantgil S., Demir E., Çelik A., ÇÖLLÜOĞLU İ. T., ATA N., YILMAZ M. B., et al.

Turkish Journal of Medical Sciences , cilt.54, sa.7, ss.1470-1477, 2024 (SCI-Expanded, Scopus, TRDizin)

40. Burden of comorbidities in heart failure patients in Türkiye

ÇAVUŞOĞLU Y., MURAT S., ŞAHİN A., ÇÖLLÜOĞLU İ. T., Ural D., YILMAZ M. B., et al.

Turkish Journal of Medical Sciences , cilt.54, sa.7, ss.1478-1487, 2024 (SCI-Expanded, Scopus, TRDizin)

41. Improving health-care planning for fracture patients in Türkiye: insights from a nationwide study Türkiye'deki kırık hastaları için sağlık hizmetleri planlamasının iyileştirilmesi: Ülke çapında bir araştırmadan içgörüler

Birinci Ş., Bingöl İ., Bakırcıoğlu S., ORAL M., Yılmaz E. T., YAŞAR N. E., et al.

Ulusal Travma ve Acil Cerrahi Dergisi , cilt.29, sa.10, ss.1184-1190, 2023 (SCI-Expanded, Scopus, TRDizin)

42. Trends in heart failure between 2016 and 2022 in Türkiye (TRends-HF): a nationwide retrospective cohort study of 85 million individuals across entire population of all ages

Celik A., Ural D., ŞAHİN A., ÇÖLLÜOĞLU İ. T., Kanik E. A., ATA N., et al.

The Lancet Regional Health - Europe , cilt.33, 2023 (ESCI, Scopus)

43. Clinical characteristics of adult and paediatric patients with familial hypercholesterolemia: A real-life cross-sectional study from the Turkish National Database

Sonmez A., Demirci I., HAYMANA C., Tasci I., Ayvalı M. O., ATA N., et al.

Atherosclerosis , cilt.375, ss.9-20, 2023 (SCI-Expanded, Scopus)

44. FALSE NEGATIVE EFFECT OF HIGH TRIGLYCERIDES CONCENTRATION ON VITAMIN D LEVELS: A BIG DATA STUDY INTERFERENCIJA VISOKE KONCENTRACIJE TRIGLICERIDA I HOLESTEROLA NA NIVOE VITAMINA D3: STUDIJA VELIKIH PODATAKA

Çağlayan M., Gonel A., Tat T. S., Celik O., Fidanci A. A., Ayvali M. O., et al.

Journal of Medical Biochemistry , cilt.42, sa.2, ss.296-303, 2023 (SCI-Expanded, Scopus)

45. The Clinical Characteristics and Outcomes of COVID-19 Patients with Pre-Existing Thyroid Dysfunction: A Nationwide Study

ŞAHİN M., Demirci I., HAYMANA C., Tasci I., EMRAL R., ÇAKAL E., et al.

Hormone and Metabolic Research , cilt.55, sa.1, ss.25-30, 2023 (SCI-Expanded, Scopus)

46. The effect of vitamin D status on non-alcoholic fatty liver disease: a population-based observational study

Dal K., UZMAN M., ATA N., Ertugrul D. T., BURSA SATICI N., Caglayan M., et al.

Endokrynologia Polska , cilt.74, sa.1, ss.63-66, 2023 (SCI-Expanded, Scopus)

47. Investigation of Therapeutic Drug Monitoring of Tacrolimus in Different Age Groups: Results from a Turkish Nationwide Study

Caglayan M., Gonel A., Cellik O., Sozuer A., Ulgu M. M., ATA N., et al.

Letters in Drug Design and Discovery , cilt.20, sa.6, ss.718-723, 2023 (SCI-Expanded, Scopus)

48. Decreased vitamin D levels in children and adolescents with Celiac disease: A nationwide cross-sectional study

AKELMA A. Z., KESKİN M., SAVAŞ ERDEVE Ş., BURSA SATICI N., Çelik O., İmrat E., et al.

Gulhane Medical Journal , cilt.64, sa.3, ss.268-273, 2022 (Scopus, TRDizin)

49. No association of Gaucher disease with COVID-19-related outcomes: a nationwide cohort study

Demirci I., Demir T., DAĞDELEN S., HAYMANA C., Tasci I., Atmaca A., et al.

Internal Medicine Journal , cilt.52, sa.3, ss.379-385, 2022 (SCI-Expanded, Scopus)

50. Higher rate of COVID-19 mortality in patients with type 1 than type 2 diabetes: A nationwide study

Demirci I., HAYMANA C., Tasci I., Satman I., Atmaca A., ŞAHİN M., et al.

Endokrynologia Polska , cilt.73, sa.1, ss.87-95, 2022 (SCI-Expanded, Scopus)

51. No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study

Atmaca A., Demirci I., HAYMANA C., Tasci I., Sahin I., ÇAKAL E., et al.

Osteoporosis International , cilt.33, sa.1, ss.273-282, 2022 (SCI-Expanded, Scopus)

52. Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers

BAŞCI S., ATA N., ALTUNTAŞ F., YİĞENOĞLU T. N., DAL M. S., KORKMAZ S., et al.

Internal and Emergency Medicine , cilt.17, sa.1, ss.135-139, 2022 (SCI-Expanded, Scopus)

53. 25-HYDROXYVITAMIN D (25-OHD) LEVELS IN TURKISH GERIATRIC POPULATION: A NATIONWIDE STUDY NIVOI 25-HIDROKSIVITAMINA D (25-OHD) U TURSKOJ GERIJATRIJSKOJ POPULACIJI: NACIONALNA STUDIJA

Çağlayan M., Sonmez C., ŞENEŞ M., Gonel A., GÜLBAHAR Ö., BURSA SATICI N., et al.

Journal of Medical Biochemistry , cilt.41, sa.4, ss.450-458, 2022 (SCI-Expanded, Scopus)

54. Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study

EMRAL R., HAYMANA C., DEMİRCİ İ., TAŞÇI İ., ŞAHİN M., ÇAKAL E., et al.

Diabetes Therapy , cilt.12, sa.11, ss.2857-2870, 2021 (SCI-Expanded, Scopus)

55. The clinical outcomes of COVID-19 infection in patients with a history of thyroid cancer: A nationwide study

ŞAHİN M., HAYMANA C., DEMİRCİ İ., TAŞÇI İ., Rıfat E., ÜNLÜTÜRK U., et al.

Clinical Endocrinology , cilt.95, sa.4, ss.628-637, 2021 (SCI-Expanded, Scopus)

56. Clinical Characteristics and Outcomes of COVID-19 Patients with Overweight and Obesity: Turkish Nationwide Cohort Study (TurCObesity)

Sahin I., HAYMANA C., Demir T., Demirci I., Tasci I., Atmaca A., et al.

Experimental and Clinical Endocrinology and Diabetes , cilt.130, sa.2, ss.115-124, 2021 (SCI-Expanded, Scopus)

57. Clinical outcomes of non-diabetic COVID-19 patients with different blood glucose levels: a nationwide Turkish study (TurCoGlycemia)

HAYMANA C., Demirci I., Tasci I., ÇAKAL E., Salman S., Ertugrul D., et al.

Endocrine , cilt.73, sa.2, ss.261-269, 2021 (SCI-Expanded, Scopus)

58. Clinical characteristics and outcomes of COVID-19 in patients with type 2 diabetes in Turkey: A nationwide study (TurCoviDia) 土耳其2型糖尿病患者患有COVID-19的临床特征和结果:一项全国性研究(TurcoviDia)

Sonmez A., Demirci I., HAYMANA C., Tasci I., DAĞDELEN S., Salman S., et al.

Journal of Diabetes , cilt.13, sa.7, ss.585-595, 2021 (SCI-Expanded, Scopus)

59. Clinical features and outcomes of COVID-19 in patients with solid tumors: Turkish National Registry Data

ÖZDEMİR N., DİZDAR Ö., YAZICI O., AKSOY S., ŞENER DEDE D., Budakoğlu B., et al.

International Journal of Cancer , cilt.148, sa.10, ss.2407-2415, 2021 (SCI-Expanded, Scopus)

60. Development and validation of clinical prediction model to estimate the probability of death in hospitalized patients with COVID-19: Insights from a nationwide database

Tanboğa I. H., CANPOLAT U., ÖZCAN ÇETİN E. H., Kundi H., Çelik O., Çağlayan M., et al.

Journal of Medical Virology , cilt.93, sa.5, ss.3015-3022, 2021 (SCI-Expanded, Scopus)

61. The prognostic role of cardiac troponin in hospitalized COVID-19 patients

Tanboğa I. H., CANPOLAT U., ÖZCAN ÇETİN E. H., Kundi H., TURAN S., Celik O., et al.

Atherosclerosis , cilt.325, ss.83-88, 2021 (SCI-Expanded, Scopus)

62. COVID-19 in hematopoietic cell transplant recipients

ALTUNTAŞ F., ATA N., YİĞENOĞLU T. N., BAŞCI S., DAL M. S., KORKMAZ S., et al.

Bone Marrow Transplantation , cilt.56, sa.4, ss.952-955, 2021 (SCI-Expanded, Scopus)

63. Unexpectedly lower mortality rates in COVID-19 patients with and without type 2 diabetes in Istanbul

Satman I., Demirci I., HAYMANA C., Tasci I., Salman S., ATA N., et al.

Diabetes Research and Clinical Practice , cilt.174, 2021 (SCI-Expanded, Scopus)

64. COVID-19 clinical course and blood groups: Turkish population-based study

Dal M. S., ATA N., ALTUNTAŞ F., BAŞCI S., YİĞENOĞLU T. N., KORKMAZ S., et al.

Turkish Journal of Medical Sciences , cilt.51, sa.4, ss.1659-1664, 2021 (SCI-Expanded, Scopus, TRDizin)

65. The role of Frailty on Adverse Outcomes Among Older Patients with COVID-19

Kundi H., ÖZCAN ÇETİN E. H., CANPOLAT U., ARAS E. S., Celik O., ATA N., et al.

Journal of Infection , cilt.81, sa.6, ss.944-951, 2020 (SCI-Expanded, Scopus)

66. Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors

BAŞCI S., ATA N., ALTUNTAŞ F., YİĞENOĞLU T. N., DAL M. S., KORKMAZ S., et al.

Journal of Oncology Pharmacy Practice , cilt.26, sa.7, ss.1676-1682, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

67. Renal function improves with the treatment of hypothyroidism

Bulur O., Dal K., Ertugrul D. T., Eser M., Kaplan Efe F., KARAKAYA S., et al.

Endocrine Research , cilt.42, sa.3, ss.246-251, 2017 (SCI-Expanded, Scopus)

68. The role of insulin - Like growth factor - 1 on steatohepatitis

Dal K., Bulur O., ATA N., Yeniova A. O., Baser S., KARAKAYA S., et al.

Acta Gastro-Enterologica Belgica , cilt.80, sa.1, ss.21-24, 2017 (SCI-Expanded, Scopus)

69. Assessment of insulin-like growth factor-1 (IGF-I) level in patients with rheumatic mitral stenosis

DEVECİ O. S., Yavuz B., Sen O., DENİZ A., ÖZKAN S., Dal K., et al.

Cardiology in the Young , cilt.25, sa.3, ss.496-500, 2015 (SCI-Expanded, Scopus)

70. The effect of glycemic control on CEA, CA 19-9, amylase and lipase levels

ATA N., Dal K., Kucukazman M., Yeniova A. Ö., KARAKAYA S., Unsal O., et al.

Open Medicine (Poland) , cilt.10, sa.1, ss.8-13, 2015 (SCI-Expanded, Scopus)

71. Serum 8 hydroxydeoxyguanosine and cytotoxin associated gene A as markers for Helicobacter pylori infection

Yeniova A. O., UZMAN M., Kefeli A., Basyigit S., ATA N., Dal K., et al.

Asian Pacific Journal of Cancer Prevention , cilt.16, sa.13, ss.5199-5203, 2015 (Scopus)

72. The relationship between glycemic control and BNP levels in diabetic patients

Dal K., ATA N., Yavuz B., Sen O., Deveci O. S., Aksoz Z., et al.

Cardiology Journal , cilt.21, sa.3, ss.252-256, 2014 (SCI-Expanded, Scopus)

73. High-sensitivity C-reactive protein is a strong predictor of non-alcoholic fatty liver disease.

Yeniova A. O., Küçükazman M., ATA N., Dal K., Kefeli A., Başyiǧit S., et al.

Hepato-gastroenterology , cilt.61, sa.130, ss.422-425, 2014 (SCI-Expanded, Scopus)

74. The association of vitamin D deficiency with non-alcoholic fatty liver disease

Küçükazman M., ATA N., Dal K., Yeniova A. Ö., Kefeli A., Basyigit S., et al.

Clinics , cilt.69, sa.8, ss.542-546, 2014 (SCI-Expanded, Scopus)

75. Decreased parasympathetic activity in patients with functional dyspepsia

Dal K., Deveci O. S., Kucukazman M., ATA N., Sen O., ÖZKAN S., et al.

European Journal of Gastroenterology and Hepatology , cilt.26, sa.7, ss.748-752, 2014 (SCI-Expanded, Scopus)

76. The metabolic syndrome is associated with complicated gallstone disease

ATA N., Kucukazman M., Yavuz B., BULUŞ H., Dal K., Ertugrul D. T., et al.

Canadian Journal of Gastroenterology , cilt.25, sa.5, ss.274-276, 2011 (Scopus)

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Açık Erişim